Global (United States, European Union and China) Ophthalmic Therapeutics/Drug Market Research Report 2019-2025
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Ophthalmic Therapeutics/Drug Quarterly Market Size Analysis
- 2.1 Ophthalmic Therapeutics/Drug Business Impact Assessment - COVID-19
- 2.1.1 Global Ophthalmic Therapeutics/Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Ophthalmic Therapeutics/Drug Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 By Players, Global Ophthalmic Therapeutics/Drug Quarterly Market Size, 2019 VS 2020
- 3.2 By Players, Ophthalmic Therapeutics/Drug Headquarters and Area Served
- 3.3 Date of Key Players Enter into Ophthalmic Therapeutics/Drug Market
- 3.4 Key Players Ophthalmic Therapeutics/Drug Product Offered
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Ophthalmic Therapeutics/Drug Segments, By Type
- 4.1 Introduction
- 1.4.1 Anti-allergy
- 1.4.2 Anti-VEGF Agents
- 1.4.3 Anti-inflammatory
- 1.4.4 Anti-glaucoma
- 1.4.5 Others
- 4.2 By Type, Global Ophthalmic Therapeutics/Drug Market Size, 2019-2021
5 Impact of Covid-19 on Ophthalmic Therapeutics/Drug Segments, By Application
- 5.1 Overview
- 5.5.1 Dry Eye
- 5.5.2 Allergies
- 5.5.3 Glaucoma
- 5.5.4 Infection
- 5.5.5 Retinal Disorders
- 5.5.6 Uveitis
- 5.5.7 Others
- 5.2 By Application, Global Ophthalmic Therapeutics/Drug Market Size, 2019-2021
- 5.2.1 By Application, Global Ophthalmic Therapeutics/Drug Market Size by Application, 2019-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Alcon
- 7.1.1 Alcon Business Overview
- 7.1.2 Alcon Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
- 7.1.3 Alcon Ophthalmic Therapeutics/Drug Product Introduction
- 7.1.4 Alcon Response to COVID-19 and Related Developments
- 7.2 Johnson and Johnson Vision Care, Inc.
- 7.2.1 Johnson and Johnson Vision Care, Inc. Business Overview
- 7.2.2 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
- 7.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Product Introduction
- 7.2.4 Johnson and Johnson Vision Care, Inc. Response to COVID-19 and Related Developments
- 7.3 Bausch & Lomb Incorporated
- 7.3.1 Bausch & Lomb Incorporated Business Overview
- 7.3.2 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
- 7.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Product Introduction
- 7.3.4 Bausch & Lomb Incorporated Response to COVID-19 and Related Developments
- 7.4 Novartis AG
- 7.4.1 Novartis AG Business Overview
- 7.4.2 Novartis AG Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
- 7.4.3 Novartis AG Ophthalmic Therapeutics/Drug Product Introduction
- 7.4.4 Novartis AG Response to COVID-19 and Related Developments
- 7.5 Merck Sharp & Dohme Corp.
- 7.5.1 Merck Sharp & Dohme Corp. Business Overview
- 7.5.2 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
- 7.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Product Introduction
- 7.5.4 Merck Sharp & Dohme Corp. Response to COVID-19 and Related Developments
- 7.6 Regeneron Pharmaceuticals Inc.
- 7.6.1 Regeneron Pharmaceuticals Inc. Business Overview
- 7.6.2 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
- 7.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Product Introduction
- 7.6.4 Regeneron Pharmaceuticals Inc. Response to COVID-19 and Related Developments
- 7.7 Allergan
- 7.7.1 Allergan Business Overview
- 7.7.2 Allergan Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
- 7.7.3 Allergan Ophthalmic Therapeutics/Drug Product Introduction
- 7.7.4 Allergan Response to COVID-19 and Related Developments
- 7.8 Pfizer Inc.
- 7.8.1 Pfizer Inc. Business Overview
- 7.8.2 Pfizer Inc. Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
- 7.8.3 Pfizer Inc. Ophthalmic Therapeutics/Drug Product Introduction
- 7.8.4 Pfizer Inc. Response to COVID-19 and Related Developments
- 7.9 Valeant
- 7.9.1 Valeant Business Overview
- 7.9.2 Valeant Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
- 7.9.3 Valeant Ophthalmic Therapeutics/Drug Product Introduction
- 7.9.4 Valeant Response to COVID-19 and Related Developments
- 7.10 Bayer AG
- 7.10.1 Bayer AG Business Overview
- 7.10.2 Bayer AG Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
- 7.10.3 Bayer AG Ophthalmic Therapeutics/Drug Product Introduction
- 7.10.4 Bayer AG Response to COVID-19 and Related Developments
- 7.11 Santen Pharmaceuticals Co. Ltd
- 7.11.1 Santen Pharmaceuticals Co. Ltd Business Overview
- 7.11.2 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
- 7.11.3 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Product Introduction
- 7.11.4 Santen Pharmaceuticals Co. Ltd Response to COVID-19 and Related Developments
- 7.12 Genentech, Inc.
- 7.12.1 Genentech, Inc. Business Overview
- 7.12.2 Genentech, Inc. Ophthalmic Therapeutics/Drug Quarterly Revenue, 2020
- 7.12.3 Genentech, Inc. Ophthalmic Therapeutics/Drug Product Introduction
- 7.12.4 Genentech, Inc. Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
- 9.1 About US
This report covers market size and forecasts of Ophthalmic Therapeutics/Drug, including the following market information:
Global Ophthalmic Therapeutics/Drug Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Ophthalmic Therapeutics/Drug Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Ophthalmic Therapeutics/Drug Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Ophthalmic Therapeutics/Drug Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Alcon, Johnson and Johnson Vision Care, Inc., Bausch & Lomb Incorporated, Novartis AG, Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals Inc., Allergan, Pfizer Inc., Valeant, Bayer AG, Santen Pharmaceuticals Co. Ltd, Genentech, Inc., etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Others
Based on the Application:
Dry Eye
Allergies
Glaucoma
Infection
Retinal Disorders
Uveitis
Others